My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 494

    1.

    Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty.

    Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J.

    Ann Intern Med. 1993 Dec 1;119(11):1105-12.PMID: 8239230 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.

    Hull RD, Raskob GE, Pineo GF, Feldstein W, Rosenbloom D, Gafni A, Green D, Feinglass J, Trowbridge AA, Elliott CG.

    Arch Intern Med. 1997 Feb 10;157(3):298-303.PMID: 9040296 [PubMed - indexed for MEDLINE]Related articles

    3.

    Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.

    Gould MK, Dembitzer AD, Sanders GD, Garber AM.

    Ann Intern Med. 1999 May 18;130(10):789-99.PMID: 10366368 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism.

    Anderson DR, O'Brien BJ.

    Pharmacoeconomics. 1997 Jul;12(1):17-29. Review.PMID: 10169385 [PubMed - indexed for MEDLINE]Related articles

    5.

    A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.

    Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH.

    J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38.PMID: 10901307 [PubMed - indexed for MEDLINE]Related articles

    6.

    Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

    Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, Hamulyák K, Francis CW, Marder VJ, Raskob GE.

    Arch Intern Med. 2001 Sep 10;161(16):1952-60. Review.PMID: 11525697 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.

    Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM.

    Ann Intern Med. 1999 May 18;130(10):800-9.PMID: 10366369 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Enoxaparin. A pharmacoeconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty.

    Dunn CJ, Goa KL.

    Pharmacoeconomics. 1996 Aug;10(2):179-90.PMID: 10163420 [PubMed - indexed for MEDLINE]Related articles

    9.

    Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

    Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE.

    Ann Intern Med. 2001 Nov 20;135(10):858-69. Review.PMID: 11712876 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.

    Rodger M, Bredeson C, Wells PS, Beck J, Kearns B, Huebsch LB.

    CMAJ. 1998 Oct 20;159(8):931-8.PMID: 9834718 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.

    Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J.

    Ann Intern Med. 1991 Apr 1;114(7):545-51.PMID: 1848054 [PubMed - indexed for MEDLINE]Related articles

    12.

    Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

    Quinlan DJ, McQuillan A, Eikelboom JW.

    Ann Intern Med. 2004 Feb 3;140(3):175-83.PMID: 14757615 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

    Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Vandenbroek MD.

    BMJ. 1991 Sep 7;303(6802):543-8. Erratum in: BMJ 1991 Nov 16;303(6812);1243. PMID: 1655136 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.

    Whang PG, Lieberman JR.

    Am J Orthop. 2002 Sep;31(9 Suppl):31-6. Review.PMID: 12349893 [PubMed - indexed for MEDLINE]Related articles

    15.

    Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis.

    O'Brien B, Levine M, Willan A, Goeree R, Haley S, Blackhouse G, Gent M.

    Arch Intern Med. 1999 Oct 25;159(19):2298-304.PMID: 10547169 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.

    [No authors listed]

    Arch Orthop Trauma Surg. 1992;111(2):110-20.PMID: 1314065 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cost effectiveness of desirudin compared with a low molecular weight heparin in the prevention of deep vein thrombosis after total hip replacement surgery.

    Levin LA, Bergqvist D.

    Pharmacoeconomics. 2001;19(5 Pt 2):589-97. Review.PMID: 11465303 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery.

    Menzin J, Colditz GA, Regan MM, Richner RE, Oster G.

    Arch Intern Med. 1995 Apr 10;155(7):757-64.PMID: 7695464 [PubMed - indexed for MEDLINE]Related articles

    19.

    A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.

    Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H.

    Thromb Haemost. 1996 Feb;75(2):246-50.PMID: 8815569 [PubMed - indexed for MEDLINE]Related articles

    20.

    Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

    van Der Heijden JF, Hutten BA, Büller HR, Prins MH.

    Cochrane Database Syst Rev. 2000;(4):CD002001. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD002001. PMID: 11034739 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity